LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2011 Health Care Conference

BURLINGTON, N.C., May 05, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Bank of America Merrill Lynch 2011 Health Care Conference in Las Vegas,

Laboratory Corporation of America(R) Holdings Announces First Quarter 2011 Results

Strong Revenue Growth Drives Adjusted EPS Excluding Amortization of $1.52, Up 8.6%, and Operating Cash Flow of $215.3 Million BURLINGTON, N.C., Apr 21, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today announced results for the quarter ended

LabCorp Commences Cash Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.

BURLINGTON, N.C., Apr 19, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (NYSE:LH) today announced the commencement of its cash tender offer for all outstanding shares of the common stock of Orchid Cellmark Inc. (NASDAQ:ORCH) for $2.80 per share.

LabCorp Announces Definitive Agreement to Acquire Orchid Cellmark Inc.

Acquisition Price of $2.80 per Share in All Cash Transaction BURLINGTON, N.C. & PRINCETON, N.J., Apr 06, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) and Orchid Cellmark Inc. (NASDAQ: ORCH), an international provider of DNA testing services

Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

BURLINGTON, N.C., Apr 04, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America Holdings (LabCorp) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and

LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest

BURLINGTON, N.C., Mar 14, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) announced today that for the period of March 12, 2011 to September 11, 2011, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will, subject to the terms

LabCorp is Scheduled to Present at the Barclays Capital 2011 Global Healthcare Conference

BURLINGTON, N.C., Mar 09, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Barclays Capital 2011 Global Healthcare Conference in Miami Beach, FL.

LabCorp is Scheduled to Speak at RBC Capital Markets' 2011 Healthcare Conference

BURLINGTON, N.C., Feb 23, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the RBC Capital Markets' 2011 Healthcare Conference in New York City, NY.

Laboratory Corporation of America(R) Holdings Announces 2010 Fourth Quarter and Full Year Results

Revenue Growth Drives Q4 Adjusted EPS of $1.34, up 15.5%, and Operating Cash Flow of $259.2 Million Board Authorizes New $500 Million Share Repurchase Program BURLINGTON, N.C., Feb 10, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today announced

LabCorp publishes the Virology Report on its newly launched "Research" web page http://www.labcorp.com/research/virology

BURLINGTON, N.C., Jan 31, 2011 (BUSINESS WIRE) -- Laboratory Corporation of America (R) Holdings (LabCorp (R) ) (NYSE: LH) today released the Virology Report on its "Research" web page, an unprecedented resource for scientists and healthcare professionals.